Sales of cough, cold and allergy (hay fever) remedies in the Netherlands are mainly reliant on seasonal factors. One important factor is the flu season, when the cold, damp weather causes national flu levels to rise in a country that enjoys a more moderate climate than many of its European neighbours.
One other important season for sales of cough, cold and allergy (hay fever) remedies is spring, when Dutch consumers are more likely to suffer from certain allergies, particularly hay fever. While incidence of hay fever fluctuate depending on specific types of pollen that affect different consumers, the general pattern of seasonal behaviour linked to allergies is supporting ongoing demand for antihistamines/allergy remedies, which is predicted to continue into the forecast period.
Private label had a solid presence in cough cold and allergy (hay fever) remedies in 2019, although its value share was much lower than in analgesics. Supermarket chains such as Albert Heijn and Jumbo, continued to gain value share of distribution of this category, in addition to offering their own private label lines, supported by consumers’ increasing confidence in choosing alternatives to major, more expensive brands.
Lofthouse of Fleetwood retained its overall leadership of cough, cold and allergy (hay fever) remedies in 2019, due to its ongoing strong position in the largest category in value sales terms of medicated confectionery. While its leading brand Fisherman's Friend retained its value share, it recorded undynamic sales growth, while competing brands such as Vicks from Procter & Gamble, and Pervasco BV, recorded stronger performances in 2019, gaining both value share from private label and smaller brands.
GSK Consumer Healthcare remained in second position in overall cough, cold and allergy (hay fever) remedies in 2019, offering its brand Otrivin, which is present in a number of categories including its leadership of nasal sprays, in addition to antihistamines/allergy remedies (systemic) with Otrivin Azelastine which continues to perform strongly, and paediatric cough/cold remedies. However, the player continued to notably lose share within nasal sprays to A Vogel from Biohorma BV, which gained further ground in 2019 due to its natural positioning, as its produced from ecologically-grown medicinal herbs and plants.
Dutch consumers are becoming increasingly aware of the sugar content of cough/cold remedies. This is prompting major players such as Sanofi-Aventis, which owns leading cough remedy brand Bisolvon to launch sugar-free versions in response to these growing concerns.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Netherlands with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Netherlands, our research will save you time and money while empowering you to make informed, profitable decisions.
The Cough, Cold and Allergy (Hay Fever) Remedies in Netherlands market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.